Faes Farma, S.A. (FAE.MC)
EUR 3.47
(0.14%)
EUR 3.47
(0.14%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 451.16 Million EUR | 2.83% |
| 2022 | 438.75 Million EUR | 10.09% |
| 2021 | 398.55 Million EUR | 4.82% |
| 2020 | 380.24 Million EUR | 6.39% |
| 2019 | 357.39 Million EUR | 10.2% |
| 2018 | 324.31 Million EUR | 18.11% |
| 2017 | 274.57 Million EUR | 20.09% |
| 2016 | 228.63 Million EUR | 11.68% |
| 2015 | 204.72 Million EUR | 6.77% |
| 2014 | 191.74 Million EUR | 6.29% |
| 2013 | 180.39 Million EUR | 2.43% |
| 2012 | 176.1 Million EUR | -7.42% |
| 2011 | 190.22 Million EUR | -6.07% |
| 2010 | 202.5 Million EUR | 54.11% |
| 2009 | 131.4 Million EUR | -32.33% |
| 2008 | 194.18 Million EUR | 4.43% |
| 2007 | 185.94 Million EUR | 0.41% |
| 2006 | 185.18 Million EUR | 11.26% |
| 2005 | 166.44 Million EUR | 2.11% |
| 2004 | 163 Million EUR | -5.96% |
| 2003 | 173.34 Million EUR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 134.63 Million EUR | -3.16% |
| 2024 Q1 | 139.02 Million EUR | -35.33% |
| 2023 FY | 451.16 Million EUR | 2.83% |
| 2023 Q3 | 108.96 Million EUR | 2.66% |
| 2023 Q4 | 214.96 Million EUR | 97.28% |
| 2023 Q1 | 130.06 Million EUR | 49.97% |
| 2023 Q2 | 106.14 Million EUR | -18.39% |
| 2022 Q2 | 105.88 Million EUR | -15.37% |
| 2022 Q3 | 121.02 Million EUR | 14.31% |
| 2022 Q4 | 86.72 Million EUR | -28.34% |
| 2022 Q1 | 125.11 Million EUR | 61.06% |
| 2022 FY | 438.75 Million EUR | 10.09% |
| 2021 Q2 | 87.28 Million EUR | -16.81% |
| 2021 FY | 398.55 Million EUR | 4.82% |
| 2021 Q4 | 77.68 Million EUR | -39.62% |
| 2021 Q3 | 128.66 Million EUR | 47.4% |
| 2021 Q1 | 104.92 Million EUR | 63.65% |
| 2020 FY | 380.24 Million EUR | 6.39% |
| 2020 Q1 | 9.13 Million EUR | -97.29% |
| 2020 Q2 | 192.17 Million EUR | 2004.46% |
| 2020 Q3 | 114.81 Million EUR | -40.26% |
| 2020 Q4 | 64.11 Million EUR | -44.16% |
| 2019 Q3 | -162.4 Million EUR | -191.35% |
| 2019 Q2 | 177.78 Million EUR | 3851.57% |
| 2019 FY | 357.39 Million EUR | 10.2% |
| 2019 Q1 | 4.49 Million EUR | -94.66% |
| 2019 Q4 | 337.52 Million EUR | 307.83% |
| 2018 Q2 | 82.49 Million EUR | -0.97% |
| 2018 Q4 | 84.21 Million EUR | 13.33% |
| 2018 FY | 324.31 Million EUR | 18.11% |
| 2018 Q1 | 83.3 Million EUR | 9.78% |
| 2018 Q3 | 74.3 Million EUR | -9.92% |
| 2017 Q3 | 196.96 Million EUR | 439.21% |
| 2017 FY | 274.57 Million EUR | 20.09% |
| 2017 Q1 | 59.8 Million EUR | -73.66% |
| 2017 Q4 | 75.87 Million EUR | -61.48% |
| 2017 Q2 | -58.06 Million EUR | -197.1% |
| 2016 FY | 228.63 Million EUR | 11.68% |
| 2016 Q4 | 227.03 Million EUR | 41405.48% |
| 2016 Q3 | 547 Thousand EUR | -42.6% |
| 2016 Q2 | 953 Thousand EUR | 853.0% |
| 2016 Q1 | 100 Thousand EUR | -99.95% |
| 2015 Q2 | 1.07 Million EUR | 973.0% |
| 2015 Q3 | 4.63 Million EUR | 331.97% |
| 2015 Q4 | 198.91 Million EUR | 4191.61% |
| 2015 FY | 204.72 Million EUR | 6.77% |
| 2015 Q1 | 100 Thousand EUR | -99.95% |
| 2014 Q3 | 268 Thousand EUR | -94.61% |
| 2014 Q4 | 186.46 Million EUR | 69476.12% |
| 2014 Q2 | 4.97 Million EUR | 13340.54% |
| 2014 FY | 191.74 Million EUR | 6.29% |
| 2014 Q1 | 37 Thousand EUR | -99.86% |
| 2013 Q2 | -43.56 Million EUR | -185.81% |
| 2013 Q3 | 146.02 Million EUR | 435.16% |
| 2013 Q4 | 27.16 Million EUR | -81.4% |
| 2013 FY | 180.39 Million EUR | 2.43% |
| 2013 Q1 | 50.77 Million EUR | 79.61% |
| 2012 Q1 | 49.24 Million EUR | 60.12% |
| 2012 Q3 | 56.29 Million EUR | 33.05% |
| 2012 FY | 176.1 Million EUR | -7.42% |
| 2012 Q4 | 28.26 Million EUR | -49.78% |
| 2012 Q2 | 42.3 Million EUR | -14.08% |
| 2011 Q1 | 56.47 Million EUR | 0.0% |
| 2011 Q4 | 30.75 Million EUR | -42.73% |
| 2011 Q3 | 53.7 Million EUR | 8.96% |
| 2011 FY | 190.22 Million EUR | -6.07% |
| 2011 Q2 | 49.28 Million EUR | -12.73% |
| 2010 Q1 | 52.7 Million EUR | 0.0% |
| 2010 FY | 202.5 Million EUR | 54.11% |
| 2010 Q2 | 53.25 Million EUR | 1.04% |
| 2009 FY | 131.4 Million EUR | -32.33% |
| 2008 FY | 194.18 Million EUR | 4.43% |
| 2007 FY | 185.94 Million EUR | 0.41% |
| 2006 FY | 185.18 Million EUR | 11.26% |
| 2005 FY | 166.44 Million EUR | 2.11% |
| 2004 FY | 163 Million EUR | -5.96% |
| 2003 FY | 173.34 Million EUR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Almirall, S.A. | 894.51 Million EUR | 49.563% |
| Laboratorio Reig Jofre, S.A. | 316.08 Million EUR | -42.735% |